CPD Activities

Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON


Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON


Starting on :07:30 AM 17 August, 2018 Venue:M. P. Shah Hospital
Ending on :08:30 AM 17 August, 2018 Max Credits:3.00
Moderator:No Activity Moderator Activity Cost: Free Order

Presenters

1. Dr. Shamsa Ahmed
MBChB (NAIROBI) 2010
M. P. Shah Hospital

Description

A discussion on the Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease

Objectives

The Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial reported that intensive glucose control prevents end-stage kidney disease (ESKD) in patients with type 2 diabetes, but uncertainty about the balance between risks and benefits exists. Here, we examine the long-term effects of intensive glucose control on risk of ESKD and other outcomes.




Online Register